We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+8.62%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$97.6B
AUM Growth
+$13.8B
Cap. Flow
+$6.88B
Cap. Flow %
7.05%
Top 10 Hldgs %
24.85%
Holding
8,027
New
582
Increased
3,285
Reduced
3,349
Closed
442

Sector Composition

Rank Sector Weight
1 Healthcare 5.21%
2 Financials 5.16%
3 Technology 4.66%
4 Consumer Discretionary 3.61%
5 Energy 3.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SAIC icon
6201
PUT
Saic
SAIC
$5.06B
$40K ﹤0.01%
+1,218
New +$42.3K
SBCF icon
6202
Seacoast Banking Corp of Florida
SBCF
$3.38B
$40K ﹤0.01%
3,327
-1,362
-29% -$15.2K
SCM icon
6203
Stellus Capital Investment Corp
SCM
$226M
$40K ﹤0.01%
2,924
-706
-19% -$10.4K
SPE
6204
Special Opportunities Fund
SPE
$141M
$40K ﹤0.01%
2,435
+1,466
+151% +$25.7K
SRCE icon
6205
1st Source
SRCE
$2.17B
$40K ﹤0.01%
1,442
-1,074
-43% -$30K
UAN icon
6206
CALL
CVR Partners
UAN
$1.34B
$40K ﹤0.01%
250
-2,010
-89% -$350K
CDMO
6207
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$40K ﹤0.01%
5,734
-868
-13% -$8.17K
GHL
6208
CALL
DELISTED
Greenhill & Co., Inc.
GHL
$40K ﹤0.01%
700
-500
-42% -$26.2K
PTLA
6209
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$40K ﹤0.01%
1,570
+1,209
+335% +$29.4K
SGYP
6210
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$40K ﹤0.01%
8,064
+3,041
+61% +$13.1K
ZU
6211
DELISTED
ZULILY INC CLASS A COMMON STOCK
ZU
$40K ﹤0.01%
+969
New +$37.1K
DOC
6212
DELISTED
PHYSICIANS REALTY TRUST
DOC
$40K ﹤0.01%
3,392
+2,919
+617% +$36K
GNK
6213
DELISTED
GENCO SHIPPING & TRADING LTD
GNK
$40K ﹤0.01%
+20,000
New +$53.4K
AMSC icon
6214
CALL
American Superconductor
AMSC
$1.47B
$39K ﹤0.01%
3,800
-350
-8% -$6.52K
CVSA
6215
CALL
Covista Inc
CVSA
$4.33B
$39K ﹤0.01%
1,100
-4,500
-80% -$155K
ATRC icon
6216
AtriCure
ATRC
$1.98B
$39K ﹤0.01%
2,211
-2,284
-51% -$33.2K
BR icon
6217
CALL
Broadridge
BR
$18.2B
$39K ﹤0.01%
1,000
+500
+100% +$18.1K
BR icon
6218
PUT
Broadridge
BR
$18.2B
$39K ﹤0.01%
1,000
CASS icon
6219
Cass Information Systems
CASS
$720M
$39K ﹤0.01%
756
+245
+48% +$11K
HBIO icon
6220
Harvard Bioscience
HBIO
$27.8M
$39K ﹤0.01%
971
+816
+526% +$35.6K
NG icon
6221
CALL
NovaGold Resources
NG
$2.57B
$39K ﹤0.01%
19,300
-15,100
-44% -$34.3K
ON icon
6222
PUT
ON Semiconductor
ON
$31.4B
$39K ﹤0.01%
4,900
-2,500
-34% -$18.2K
PPA icon
6223
Invesco Aerospace & Defense ETF
PPA
$8.39B
$39K ﹤0.01%
+1,250
New +$36.4K
QID icon
6224
PUT
ProShares UltraShort QQQ
QID
$266M
$39K ﹤0.01%
9
+1
+13% +$5.42K
GBL
6225
DELISTED
GAMCO Investors, Inc.
GBL
$39K ﹤0.01%
843
+425
+102% +$17.5K

Similar funds

Barclays's Q4 2013 Portfolio in Review

As of Q4 2013, Barclays held 8,027 positions worth $97.6B, up 16% from $83.8B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Barclays deployed $6.88B of net new capital in Q4 2013, opening 582 new positions and adding to 3,285 existing holdings. Its largest new stake was LyondellBasell Industries: 1,615,904 shares worth $129M.

By sector, the portfolio is most concentrated in Healthcare at 5.2% of assets, up from 4.2% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was iShares 20+ Year Treasury Bond ETF, an estimated $418M trimmed.

  • Barclays's largest Q4 2013 buy was LyondellBasell Industries: 1,615,904 shares worth $129M.
  • Barclays added most to State Street SPDR S&P 500 ETF Trust in Q4 2013, an estimated $3.38B increase.
  • Barclays's biggest Q4 2013 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $418M.
  • Barclays fully exited ONYX PHARMACEUTICALS INC in Q4 2013, selling an estimated $193M.
  • Barclays's ten largest holdings make up 25% of its $97.6B portfolio in Q4 2013.
  • Barclays opened 582 new positions and closed 442 in Q4 2013.
  • Barclays's portfolio value rose 16% quarter-over-quarter to $97.6B.

Based on Barclays's 13F filing for Q4 2013, filed 13 Feb 2014.